Comparative Urine Proteomic Studies of Overactive Bladder in Humans

Summary

This study is being done to evaluate the use of a new technology (urine proteomics) - the study of proteins in the urine to identify urine markers of overactive bladder (OAB) from a simple voided urine specimen.

Timeline

Start

2010-08

Primary completion

2011-09

Completion

2011-09

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Fesoterodine; p = 0.19; Mean Difference (Final Values) 1.53; t-test, 2 sided NCT01367886 ↗

registry analysis (superiority or other test); Fesoterodine; p = 0.18; Mean Difference (Final Values) 0.34; t-test, 2 sided NCT01367886 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fesoterodine	Other / unclassified	4 mg	Oral

Indications